Astrana Health (ASTH) vs Huron Consulting Group (HURN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Astrana Health (ASTH) has outperformed Huron Consulting Group (HURN) over the past year, gaining 22.5% versus a gain of 4.5%. Over five years, HURN leads with a +205.3% price change compared with -48.0% for ASTH. Huron Consulting Group is the larger company by market cap ($2.53 billion vs $1.79 billion), about 1.4 times the size.
On valuation, Astrana Health trades at a lower forward P/E (9.9x vs 15.0x for Huron Consulting Group).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASTH | HURN |
|---|---|---|
| Share price | $36.15 | $159.20 |
| Market cap | $1.79B | $2.53B |
| 1-day change | -2.67% | +1.65% |
| YTD return | +49.70% | -9.43% |
| 1-year return | +22.45% | +4.47% |
| 5-year return | -48.05% | +205.28% |
| P/E ratio (TTM) | 43.55 | 23.98 |
| Forward P/E | 9.94 | 15.03 |
| EPS (TTM) | $0.83 | $6.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $1.70B |
| Revenue growth (YoY) | — | +11.65% |
| Net income (latest FY) | — | $105.04M |
| Gross margin | — | 33.94% |
| Operating margin | — | 10.51% |
| Net margin | — | 6.18% |
| 52-week high | $51.60 | $186.78 |
| 52-week low | $18.08 | $84.88 |
| Distance from 52-week high | -29.94% | -14.77% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +42.93% | +19.82% |
| Average volume | 462.64K | 280.21K |
| Shares outstanding | 49.60M | 15.91M |
| Employees | 3,000 | 9,248 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ASTH has outperformed HURN by 18.0 percentage points over the past year.
- Astrana Health trades at a higher earnings multiple (43.6x vs 24.0x trailing P/E).
About Astrana Health
ASTH stock →Astrana Health, Inc., a healthcare management company, provides medical care services in the United States. The company operates through three segments: Care Partners, Care Delivery, and Care Enablement.
Consumer Discretionary · Professional Services · 3,000 employees
About Huron Consulting Group
HURN stock →Huron Consulting Group Inc. provides global professional services in the United States and internationally.
Consumer Discretionary · Professional Services · 9,248 employees
ASTH vs HURN FAQ
Which is bigger, Astrana Health or Huron Consulting Group?
Huron Consulting Group (HURN) is larger, with a market capitalization of $2.53B compared with $1.79B for Astrana Health (ASTH).
Which stock has performed better over the past year, ASTH or HURN?
ASTH returned +22.45% over the past 12 months, compared with +4.47% for HURN (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, ASTH or HURN?
HURN has the lower trailing P/E at 24.0, versus 43.6 for ASTH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Astrana Health and Huron Consulting Group in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.